An image of a stock chart with money, a calculator and a pen lying on it.
Markets

CME Group Now Rated a “Buy” at UBS (CME)

Futures exchange operator CME Group Inc. ( CME ) on Friday saw its rating and price target boosted by analysts at UBS.

The firm said it upgraded CME from "Neutral" to "Buy" with a $318 price target. That target suggests a 20% upside to the stock's Thursday closing price of $266.25.

Analysts at UBS noted the company has both cyclical and secular growth potential.

CME shares rose $3.75, or +1.4%, in premarket trading Friday.

The Bottom Line

Shares of CME Group ( CME ) have a 2.10% dividend yield, based on last night's closing stock price of $266.25. The stock has technical support in the $250-$260 price area. If the shares can firm up, we see overhead resistance around the $280 price level.

CME Group Inc. ( CME ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

CME

Other Topics

Stocks

Latest Markets Videos